Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1581-1589

  MacDonald, Kelly S ^a,f   Fowke, Keith R ^b   Kimani, Joshua ^a   Dunand, Viviane A ^a   Nagelkerke, Nico J D ^b,c   Ball, T Blake ^b   Oyugi, Julius ^a   Njagi, Ephantus ^a   Gaur, Lakshmi K ^d   Brunham, Robert C ^b   Wade, Judy ^g   Luscher, Mark A ^g   Krausa, Peter ^e   Rowland Jones, Sarah ^e   Ngugi, Elizabeth ^a   Bwayo, Job J ^a   Plummer, Francis A ^a,b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF MANITOBA   (Canada)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d PUGET SOUND BLOOD CENTER   (United States)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f MOUNT SINAI HOSPITAL   (Canada)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; FEMALE; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTITUTION; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; KENYA; LONGITUDINAL STUDIES; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; PROSTITUTION; TIME FACTORS;

EID: 0034120188     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315472     Document Type: Article

References (60)

1. 1. Royce RA, Sena A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
2. 2. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-65.
3. 3. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-93.
4. 4. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
5. 5. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-62.
6. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
7. 7. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
8. 8. Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-9.
9. 9. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
10. 10. Langlade-Demoyen P, Ngo-Giang-Huong N, Ferchal F, Oksenhendler E. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J Clin Invest 1994;93:1293-7.
11. 11. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HLV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
12. 12. Kaul R, Trabattoni D, Bwayo JJ, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-9.
13. 13. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-7.
14. 14. Hill AV, Elvin J, Willis AC, et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992;360:434-9.
15. 15. Just JJ. Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome: a review of the literature examining associations with HLA. Hum Immunol 1995;44:156-69.
16. 16. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-11.
17. 17. Hendel H, Caillat-Zueman S, Lebuanec H, et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6.
18. 18. Klein MR, Keet IP, D'Amaro J, et al. Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men. J Infect Dis 1994;169:1244-9.
19. 19. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348:1347-51.
20. 20. Fowke KR, Dong T, Rowland-Jones SL, et al. HIV-1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV-1 infection or enhanced β-chemokine production. AIDS Res Hum Retroviruses 1998;14:1521-30.
21. 21. Anzala AO, Ball TB, Rostron T, O'Brien SJ, Plummer FA, Rowland-Jones SL. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998;351:1632-3.
22. 22. Rowland-Jones SL, Dong T, Fowke KR, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758-65.
23. 23. Dawood MR, Allan R, Fowke K, Embree J, Hammond GW. Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction. J Clin Microbiol 1992;30:2279-83.
24. 24. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991;163:233-9.
25. 25. Hopkins KA. Basic Microlymphocytotoxicity test. In: Zachary A, Teresi G, eds. An immunogenetics laboratory manual. Lecnnox, Kansas: American Society for Histocompatibility, 1990:195-201.
26. 26. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991;11:298-300, 302.
27. 27. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993;90:2842-5.
28. 28. Bunce M, CM ON, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQBI by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
29. 29. Krausa P, Bodmer JG, Browning MJ. Defining the common subtypes of HLA A9, A10, A28 and A19 by use of ARMS/PCR. Tissue Antigens 1993;42:91-9.
30. 30. Dunand VA, Ng CM, Wade JA, Bwayo J, Plummer FA, MacDonald KS. HLA-DR 52-and 51-associated DRB1 alleles in Kenya, east Africa. Tissue Antigens 1997;49:397-402.
31. 31. Erlich H, Bugawan T, Begovich AB, et al. HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet 1991;18:33-55.
32. 32. Mitchell LA, Tingle AJ, MacWilliam L, et al. HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis 1998;177: 5-12.
33. 33. Shaffer AL, Falk-Wade JA, Tortorelli V, et al. HLA-DRw52-associated DRB1 alleles: identification using polymerase chain reaction-amplified DNA, sequence-specific oligonucleotide probes, and a chemiluminescent detection system. Tissue Antigens 1992;39:84-90.
34. 34. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
35. 35. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol Today 1996;17:261-6.
36. 36. Sidney J, Grey HM, Southwood S, et al. Definition of an HLA-A3 like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol 1996;45:79-93.
37. 37. del Guercio MF, Sidney J, Hermanson G, et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 1995;154:685-93.
38. 38. Greggio NA, Cameran M, Giaquinto C, Zacchello F, Koroliuk D, Colizzi V. DNA HLA-DRB1 analysis in children of positive mothers and estimated risk of vertical HIV transmission. Dis Markers 1993;11:29-35.
39. 39. Cruse JM, Brackin MN, Lewis RE, Meeks W, Nolan R, Brackin B. HLA disease association and protection in HIV infection among African Americans and Caucasians. Pathobiology 1991;59:324-8.
40. 40. Rohowsky-Kochan C, Skurnick J, Molinaro D, Louria D. HLA antigens associated with susceptibility/resistance to HIV-1 infection. Hum Immunol 1998;59:802-15.
41. 41. Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: determination by an automated sequence-based typing method. Proc Natl Acad Sci USA 1995;92:12374-8.
42. 42. MacDonald K, Embree J, Njenga S, et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998;177:551-6.
43. 43. MacDonald K, Castillo J, Embree J, et al. Class I MHC polymorphism and mother to child HIV-1 transmission in Kenya [abstract 210]. In: Abstracts of the 12th World AIDS Conference (Geneva). Stockholm: International AIDS Society 1998:31131.
44. 44. Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999; 50:201-12.
45. 45. Threlkeld SC, Wentworth PA, Kalams SA, et al. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J Immunol 1997;159: 1648-57.
46. 46. Browning M, Krausa P. Genetic diversity of HLA-A2: evolutionary and functional significance. Immunol Today 1996;17:165-70.
47. s47. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997;100:503-13.
48. 48. Tanigaki N, Fruci D, Chersi A, Falasca G, Tosi R, Buller RH. HLA-A2 binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. Hum Immunol 1994;39:155-62.
49. 49. Barouch D, Friede T, Stevanovic S, et al. HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 1995;182: 1847-56.
50. 50. Wilson CC, Kalams SA, Wilkes BM, et al. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J Virol 1997;71:1256-64.
51. 51. Rowland-Jones S, Colbert RA, Dong T, et al. Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705. AIDS 1998;12:1391-3.
52. 52. Ferrari G, Humphrey W, McElrath MJ, et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997;94:1396-401.
53. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med 1995;181:1285-92.
54. + T cell responses associated with control of viremia. Science 1997; 278:1447-50.
55. +, CD8 T cells and is restricted to the DR region of the MHC complex. J Immunol 1988;140:3610-6.
56. 56. Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol 1993;23:425-32.
57. 57. Newton-Nash DK, Eckels DD. Differential effect of polymorphism at HLA-DR1 β-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J Immunol 1993;150:1813-21.
58. 58. Plebanski M, Lee EA, Hannan CM, et al. Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming. Nat Med 1999;5:565-71.
59. 59. McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol 1997;15:271-96.
60. 60. Goh WC, Markee J, Akridge RE, et al. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J Infect Dis 1999;179:548-57.